The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 43

More JCP Articles

JCP
Intravenous Ketamine for Treatment-Resistant Depression
Original Research

September 12, 2022

The clinical effectiveness of ketamine for suicidal ideation and treatment-resistant depression outside of controlled clinical trials is unclear. This article reports clinical outcomes of a large cohort treated with…
, , , et al
JCP
Patient Functioning and Life Engagement: Treatment Goals in MDD
Insights

September 7, 2022

Patients with MDD often report lack of motivation and energy and a feeling of disengagement from their own lives. Here, experts discuss treatment strategies that may be favorable for…
, , , et al
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder
Academic Highlights

September 7, 2022

Patients with MDD often report lack of motivation and energy and a feeling of disengagement from their own lives. Here, experts discuss treatment strategies that may be favorable for…
, , , et al
JCP
Reasons for Switching Antipsychotic Treatments
Original Research

September 5, 2022

Based on prescription records and prescriber notes, almost half of antipsychotic switches were due to side effects, and women were especially likely to be switched due to intolerability or…
, , , et al
JCP
In Memoriam: Charles Bowden, MD, 1938–2022
In Memoriam

September 5, 2022

Over his long and distinguished career, Charles Bowden, MD, was a tireless advocate for bipolar disorder patients and an inspiration to colleagues. Trisha Suppes and Gary Sachs reflect on…
,
JCP
Machine Learning Prediction of Suicide Risk
Original Research

August 31, 2022

Suicide assessment prompted by prediction models may be intrusive to patients with no history of suicidality. This study examined if machine learning models identify patients with high suicide risk…
, , , et al
JCP
Impact of SUD on COVID-19 Outcomes
Original Research

August 29, 2022

Identifying risk factors that predispose individuals to negative COVID-19 outcomes is important. The current study examined the association between substance use disorders, psychiatric diagnosis, and COVID-19–related clinical outcomes.
, , , et al
JCP
Positive Predictive Value
Commentary

August 24, 2022

In this Commentary, the author posits that knowledge about positive predictive value—the probability a person identified as ill by a screening test does indeed have the illness—is important for…
JCP
Machine Learning Prediction of ECT Responses
Original Research

August 24, 2022

Predicting individual therapeutic outcomes would be clinically useful to help patients accept electroconvulsive therapy (ECT) for treating depression. This study sought to develop a prediction model for ECT response…
, , , et al
JCP
Omega-3 Fatty Acids for MDD With High Inflammation
Original Research

August 22, 2022

This study investigated whether dosage or inflammation levels affect response to omega-3s in MDD patients.
, , , et al
JCP
Patient Functioning and Life Engagement: Treatment Goals in Schizophrenia
Insights

August 17, 2022

Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that…
, , , et al
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia
Academic Highlights

August 17, 2022

Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that…
, , , et al

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe